Abstract

Context: Fetal Growth Restriction (FGR) is the single largest contributing factor to perinatal morbidity in nonanomalous foetuses. This research was conducted in the Department of Obstetrics and Gynaecology in a tertiary care teaching Hospital which included 100 singleton pregnant women with FGR. Aims: 1. To evaluate the maternal risk factors as possible contributors to FGR and related perinatal mortality. 2. To establish the decision-to-delivery time interval in growth restricted fetuses in correlation to gestational age and doppler examination. Methods and Material: Socio-demographic, maternal risk, Diagnosis- delivery interval in FGR and neonatal morbidities were studied. Serial deciding doppler were considered for evaluation of the perinatal outcome and mode of delivery. Statistical Analysis used: The association between doppler category and maternal risk factors was assessed by Chi-square test. The continuous variables were presented as mean ± standard deviation (SD) and the difference between the means was calculated by student’s ‘t’ test. Results: 76% women suffered concomitant comorbidities which could possibly contribute to the genesis of fetal growth restriction. 38% women had hypertensive disorders of pregnancy. Majority of women with FGR ~ 72% delivered by caesarean section. The doppler findings were abnormal among 60 subjects with preterm intervention and poor perinatal outcome. Conclusions: Obstetric Doppler has helped in early detection and timely intervention in babies with FGR with significant improvements in perinatal outcomes. Key Messages: The relevance of doppler in Obstetrics has shown utmost importance as a diagnostic tool in detection of fetal compromise and aiding for optimization for timing of intervention. This tool of Obstetric doppler has enhanced tremendous surveillance to growth restricted fetuses

• 1.   Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009;6(Suppl 3):332-6
• 2.   Baschat AA. Doppler application in the delivery timing of the preterm growth- restricted fetus: another step in the right direction. Ultrasound in Obstetrics and Gynecology:The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2004;23(2):111-8.
• 3.   Vandenbosche RC, Kirchner JT. Intrauterine growth retardation. Am Fam Physician. 1998 Oct 15;58(6):1384-90, 1393-4. PMID: 9803202.
• 4.   Saleem T, Sajjad N, Fatima S, Habib N, Ali SR, Qadir M. Intrauterine growth retardation--small events, big consequences. Ital J Pediatr. 2011;37:41. Published 2011 Sep 7. doi:10.1186/1824-7288-37-41
• 5.   Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016;10:67-83. Published 2016 Jul 14.
• 6.   Ashwani N, NeelaAruna Rekha, Babu M.S, C. Suresh Kumar, O. Tejo Pratap. Maternal risk factors associated with intrauterine growth restriction: hospital based study. Int J Med Res Rev 2016;4(12):2125-2129.doi:10.17511/ijmrr.2016. i12.08.
• 7.   Saleem T, Sajjad N, Fatima S, Habib N, Ali SR, Qadir M. Intrauterine growth retardation--small events, big consequences. Ital J Pediatr. 2011;37:41. Published 2011 Sep 7. doi:10.1186/1824-7288-37-41

Data Sharing Statement

Funding